Validating CGM for GDM
Icahn School of Medicine at Mount Sinai · NCT06858787
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 150
- US sites recruiting
- 3
- Study start
- October 2, 2025
- Record last updated
- August 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a prospective pilot study to assess the validity of using a continuous glucose monitor (CGM) in diagnosing gestational diabetes mellitus (GDM). Pregnant individuals between the ages of 18-50 years old receiving prenatal care at Mount Sinai Hospital (e..g, E-Level clinic and Faculty Practice Associates) will be enrolled. Potential participants will be approached during their prenatal care appointments. Participants will complete an informed consent form for the study during their standard-of-care prenatal appointments at our institution.
Being studied: Continuous glucose monitor
Conditions: Gestational Diabetes Mellitus (GDM)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Ages 18-50
- Singleton pregnancy between 24-32 weeks gestational age
- Prenatal care and delivery at Mount Sinai Hospital
Exclusion Criteria
- Multiple fetal gestation
- Preexisting diabetes
- Concurrent use of steroids
- Anomalous fetus
- Insufficient prenatal care (identified as missing half the recommended visits or establishing care after 20 weeks gestation)
- Unable to tolerate oral glucose test
Recruiting US locations
Mount Sinai West
New York, NY 10019
Site contact: Shelly Thai, MD · 917-755-3033 · shelly.thai2@mountsinai.org
Icahn School of Medicine at Mount Sinai
New York, NY 10029
Site contact: Victoria Ly, MD · 212-241-5681 · victoria.ly@mssm.edu
Mount Sinai South Nassau
Oceanside, NY 11572
Site contact: Dina El Kady, MD
Study contacts (from the official record)
- Nicola F Tavella, MPH · 212-241-3888 · nicola.tavella@mssm.edu
- Victoria Ly, MD · 212-241-5681 · victoria.ly@mssm.edu
Similar studies in New York
All diabetes studies in New York →- RecruitingPhase 1Overnight stay mentioned
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
GentiBio, Inc
- Location
- New York, NY + 8 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79